Catalent
CTLT
#1737
Rank
โ‚น1.035 T
Marketcap
โ‚น5,703
Share price
0.00%
Change (1 day)
20.71%
Change (1 year)
Catalent is an American pharmaceutical contract research and development company.

Catalent (CTLT) - Total debt

Total debt on the balance sheet as of September 2024 : โ‚น444.42 Billion

According to Catalent's latest financial reports the company's total debt is โ‚น444.42 Billion. A companyโ€™s total debt is the sum of all current and non-current debts.

Catalent - Total debt on balance sheet (from 2013 to 2024)

Total debt by year

Year Total debt Change
2023-06-30โ‚น398.81 B19.8%
2022-06-30โ‚น332.90 B37.44%
2021-06-30โ‚น242.22 B5.43%
2020-06-30โ‚น229.74 B12.61%
2019-06-30โ‚น204.01 B9.53%
2018-06-30โ‚น186.25 B38.6%
2017-06-30โ‚น134.39 B7.01%
2016-06-30โ‚น125.58 B5%
2015-06-30โ‚น119.60 B-26.42%
2014-06-30โ‚น162.55 B1.46%
2013-06-30โ‚น160.22 B7.56%
2012-06-30โ‚น148.96 B

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
Supernus Pharmaceuticals
SUPN
โ‚น3.79 B-99.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Aerie Pharmaceuticals
AERI
โ‚น30.27 B-93.19%๐Ÿ‡บ๐Ÿ‡ธ USA
Jazz Pharmaceuticals
JAZZ
โ‚น487.67 B 9.73%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Intercept Pharmaceuticals
ICPT
โ‚น20.11 B-95.47%๐Ÿ‡บ๐Ÿ‡ธ USA